Article Details

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) Receives Consensus Rating of “Buy” from Brokerages

Retrieved on: 2019-12-07 02:45:00

Tags for this article:

Click the tags to see associated articles and topics

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) Receives Consensus Rating of “Buy” from Brokerages. View article details on hiswai:

Excerpt

<div><b>WINTON GROUP</b> Ltd purchased a new stake in AcelRx Pharmaceuticals in the 2nd quarter valued at $40,000. Wells Fargo & Company MN grew its ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo